Excessive daytime sleepiness in idiopathic restless legs syndrome: Characteristics and evolution under dopaminergic treatment

European Neurology

Volumn 62, Issue 3, 2009, Pages 176-179

  Kallweit, Ulf ^a   Siccoli, Massimiliano M ^a   Poryazova, Rositsa ^a   Werth, Esther ^a   Bassetti, Claudio L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Dopaminergic treatment; Excessive daytime sleepiness; Hypersomnia; Polysomnography; Restless legs syndrome

Indexed keywords

CABERGOLINE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DISEASE COURSE; DOPAMINERGIC ACTIVITY; EPWORTH SLEEPINESS SCALE; HUMAN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SLEEP TIME;

DISORDERS OF EXCESSIVE SOMNOLENCE; DOPAMINE AGONISTS; HUMANS; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES;

EID: 67650155829     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228261     Document Type: Article

References (25)

1. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C: Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141. (Pubitemid 30482720)
2. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K: Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-1068. (Pubitemid 30151846)
3. Bassetti CL, Mauerhofer D, Gugger D, Mathis J, Hess CW: Restless legs syndrome: a clinical study of 55 patients. Eur Neurol 2001;45:67-74. (Pubitemid 32215793)
4. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C: Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196-202. (Pubitemid 38140407)
5. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003;4:101-119.
6. Walters AS: Toward a better definition of the restless legs syndrome. Mov Disord 1995;61:562-569.
7. Walters AS, LeBrocq C, Dhar A, et al: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132. (Pubitemid 36527232)
8. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespperance P: Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65. (Pubitemid 27032881)
9. Bonati MT, Ferrini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G: Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003;126:1485-1492. (Pubitemid 36644391)
10. Allen RP: Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004;5:385-391. (Pubitemid 38842738)
11. Collado-Seidel V, Kohnen R, Samtleben W, Hildebrand GF, Oertel WH, Trenkwalder C: Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 1998;31:324-328. (Pubitemid 28106426)
12. Popp R, Geisler P, Hirn C, Zulley J, Hayak G: Increased daytime sleepiness in untreated RLS patients. J Sleep Res 2006;15(suppl 1):90.
13. Clavadetscher SC, Gugger M, Bassetti CL: Restless legs syndrome: clinical experience with long-term treatment. Sleep Med 2004;5:495-500. (Pubitemid 39194061)
14. Holmes R, Metta V, Tluk S, et al: Nature and variants of idiopathic restless legs syndrome in secondary care: observations in 152 patients in the UK. Mov Disord 2006;21:438-439.
15. Winkelman JW, Finn L, Young T: Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006;7:545-552. (Pubitemid 44480745)
16. Bader G, Ohayon MM: Prevalence of restless legs in the general population of Sweden. Sleep 2003;26:A336.
17. Stiasny K, Möller JC, Oertel WH: Safety of pramipexole in patients with restless legs syndrome. Neurology 2000;55:1589-1590.
18. Möller JC, Körner Y, Cassel W, et al: Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome. Sleep Med 2006;7:333-339. (Pubitemid 43792897)
19. Johns MW: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
20. Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, UCLA Brain Information Service/Brain Research Institute, 1968.
21. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S: Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-524.
22. Monti JM, Monti D: The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 2007;11:113-133.
23. Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, Lai RY, Halldin C, Farde L: Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006;129:2017-2028. (Pubitemid 44289067)
24. Montplaisir J, De Champlain J, Young SN, Missaka K, Sourkes TL, Walsh J, Remillard J: Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF. Neurology 1982;32:1299-1302. (Pubitemid 13231406)
25. Bassetti CL, Clavadetscher S, Gugger M, Hess CW: Pergolide-associated 'sleep attacks' in a patient with restless legs syndrome. Sleep Med 2002;3:275-277.